Plasma concentration of pioglitazone in patients with type 2 diabetes on hemodialysis.
Abe
Masanori
M
Kikuchi
Fumito
F
Okada
Kazuyoshi
K
Matsumoto
Koichi
K
D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006207:Half-Life; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D000077205:Pioglitazone; D006435:Renal Dialysis; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone